Hematopoietic stem cell

Hematopoiesis_simple.svg

== Hematopoietic Stem Cell ==

Hematopoietic stem cells (HSCs) are the stem cells that give rise to other blood cells. This process is called hematopoiesis. In hematopoiesis, the HSCs reside in the bone marrow and differentiate into various types of blood cells, including red blood cells, white blood cells, and platelets.

Characteristics

Hematopoietic stem cells are characterized by their ability to self-renew and differentiate into multiple blood cell lineages. They are typically identified by specific cell surface markers, such as CD34 and CD38.

Types of Hematopoietic Stem Cells

HSCs can be broadly classified into two types:

• Long-term HSCs (LT-HSCs): These cells have the ability to self-renew and sustain hematopoiesis over the lifetime of an individual.
• Short-term HSCs (ST-HSCs): These cells have a limited capacity for self-renewal and contribute to hematopoiesis for a shorter duration.

Sources of Hematopoietic Stem Cells

Hematopoietic stem cells can be obtained from several sources:

• Bone marrow: The traditional source of HSCs, harvested directly from the bone marrow.
• Peripheral blood: HSCs can be mobilized from the bone marrow into the bloodstream and collected through a process called apheresis.
• Umbilical cord blood: HSCs can be collected from the blood remaining in the umbilical cord and placenta after birth.

Clinical Applications

Hematopoietic stem cells are used in various clinical applications, primarily in the treatment of hematologic diseases such as leukemia, lymphoma, and aplastic anemia. The transplantation of HSCs, known as hematopoietic stem cell transplantation (HSCT), can restore normal hematopoiesis in patients with these conditions.

Research and Future Directions

Research on hematopoietic stem cells is ongoing, with a focus on understanding the mechanisms of self-renewal and differentiation, improving transplantation outcomes, and exploring new therapeutic applications. Advances in gene therapy and regenerative medicine hold promise for expanding the use of HSCs in treating a wider range of diseases.

See Also

• Stem cell
• Hematopoiesis
• Bone marrow
• Leukemia
• Lymphoma
• Aplastic anemia
• Gene therapy
• Regenerative medicine